Archivio istituzionale della ricerca dell'Università degli Studi di Palermo

CRAXI, Antonio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 46.408
EU - Europa 17.987
AS - Asia 16.180
SA - Sud America 2.702
Continente sconosciuto - Info sul continente non disponibili 1.847
AF - Africa 473
OC - Oceania 55
Totale 85.652
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 45.532
SG - Singapore 6.111
RU - Federazione Russa 4.632
CN - Cina 4.049
IT - Italia 3.824
BR - Brasile 2.066
FI - Finlandia 2.022
HK - Hong Kong 1.586
DE - Germania 1.402
VN - Vietnam 1.362
UA - Ucraina 1.284
PL - Polonia 989
GB - Regno Unito 961
IE - Irlanda 812
FR - Francia 766
BD - Bangladesh 609
JP - Giappone 546
CA - Canada 429
IN - India 392
SE - Svezia 365
KR - Corea 347
TR - Turchia 244
RO - Romania 189
AR - Argentina 167
MX - Messico 163
NL - Olanda 150
IQ - Iraq 137
CO - Colombia 119
EC - Ecuador 114
AT - Austria 101
ZA - Sudafrica 97
CI - Costa d'Avorio 96
BE - Belgio 91
VE - Venezuela 79
ES - Italia 78
ID - Indonesia 77
UZ - Uzbekistan 76
PK - Pakistan 71
SA - Arabia Saudita 67
JM - Giamaica 65
PH - Filippine 59
CL - Cile 57
IR - Iran 54
MY - Malesia 54
MA - Marocco 53
CR - Costa Rica 52
EG - Egitto 49
KE - Kenya 48
AU - Australia 45
CH - Svizzera 40
PY - Paraguay 38
CZ - Repubblica Ceca 37
NP - Nepal 37
TH - Thailandia 37
HN - Honduras 34
AZ - Azerbaigian 33
BG - Bulgaria 33
AE - Emirati Arabi Uniti 31
GR - Grecia 31
LB - Libano 28
TN - Tunisia 28
NI - Nicaragua 27
JO - Giordania 26
DK - Danimarca 25
DZ - Algeria 24
EE - Estonia 22
LT - Lituania 22
PE - Perù 22
TW - Taiwan 20
BO - Bolivia 19
EU - Europa 18
AL - Albania 17
GT - Guatemala 17
KG - Kirghizistan 17
KZ - Kazakistan 17
UY - Uruguay 17
TT - Trinidad e Tobago 16
DO - Repubblica Dominicana 15
OM - Oman 14
PA - Panama 14
SN - Senegal 14
BY - Bielorussia 13
IL - Israele 13
GE - Georgia 12
PT - Portogallo 11
SV - El Salvador 11
NG - Nigeria 10
PR - Porto Rico 10
PS - Palestinian Territory 10
RS - Serbia 10
BA - Bosnia-Erzegovina 9
ET - Etiopia 9
MD - Moldavia 9
BH - Bahrain 8
XK - ???statistics.table.value.countryCode.XK??? 8
HR - Croazia 7
HU - Ungheria 7
MM - Myanmar 7
NZ - Nuova Zelanda 7
SI - Slovenia 7
Totale 83.706
Salva come PNG Salva come JPEG
Città #
Fairfield 5.453
Ashburn 5.273
Singapore 4.339
San Jose 2.983
Woodbridge 2.684
Chandler 2.170
Seattle 2.163
Wilmington 2.157
Houston 2.150
Cambridge 1.908
Hong Kong 1.515
Ann Arbor 1.348
Zgierz 881
Council Bluffs 854
Palermo 836
Dublin 804
Medford 729
Moscow 714
New York 680
Jacksonville 663
Beijing 604
Altamura 573
Des Moines 554
Santa Clara 554
Los Angeles 550
Tokyo 511
Nanjing 491
Boardman 479
Helsinki 471
Ho Chi Minh City 466
Princeton 462
Frankfurt am Main 429
Lawrence 410
Lauterbourg 405
San Diego 354
Dallas 342
Chicago 333
Hanoi 329
Dearborn 225
Sunnyvale 209
Tulsa 197
São Paulo 191
The Dalles 185
Buffalo 183
Milan 181
Shenyang 166
London 165
Hefei 160
Phoenix 157
Jinan 155
Nanchang 153
Changsha 129
Hebei 116
Orem 111
Tianjin 110
Jiaxing 109
Rome 109
Nuremberg 106
Atlanta 104
Columbus 104
Toronto 101
Abidjan 96
Ludwigshafen am Rhein 95
Istanbul 89
San Paolo di Civitate 88
Zhengzhou 85
Seongnam 83
Brussels 82
Denver 80
Brooklyn 77
Chennai 77
Warsaw 75
Amsterdam 74
Izmir 74
Saint Petersburg 70
Montreal 68
Guangzhou 67
Ningbo 66
Springfield 61
Haiphong 59
Rio de Janeiro 59
Washington 59
Munich 58
Paris 57
Brasília 55
San Francisco 54
Da Nang 53
Falls Church 53
Hangzhou 53
Tashkent 53
Baghdad 52
Mumbai 52
Johannesburg 51
Kumar 50
Philadelphia 50
Verona 48
Shanghai 46
Miami 45
Redwood City 45
Boston 44
Totale 54.550
Salva come PNG Salva come JPEG
Nome #
EASL Clinical Practice Guidelines: management of hepatitis C virus infection 525
Hepatitis C Virus Eradication by Direct Antiviral Agents Improves Carotid Atherosclerosis in patients with Severe Liver Fibrosis 506
The severity of steatosis influences liver stiffness measurement in patients with nonalcoholic fatty liver disease 385
Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016–2030 379
Alexithymia and personality traits of patients with inflammatory bowel disease 368
Efficacy of boceprevir, an NS3 protease inhibitor, in combination with peginterferon alfa-2b and ribavirin in treatment-naive patients with genotype 1 hepatitis C infection (SPRINT-1): an open-label, randomised, multicentre phase 2 trial 366
Transmembrane 6 Superfamily Member 2 Gene Variant Disentangles Nonalcoholic Steatohepatitis From Cardiovascular Disease 359
A meta-analysis of survival rates of untreated patients in randomized clinical trials of hepatocellular carcinoma. 353
Acute polymyositis during treatment of acute hepatitis C with pegylated interferon alpha-2b 350
Visceral adiposity index is associated with significant fibrosis in patients with non-alcoholic fatty liver disease 341
HBV reactivation in patients with HCV/HBV cirrhosis on treatment with direct-acting antivirals 341
Hepatitis B virus reactivation and alemtuzumab therapy 339
Liver eosinophilic infiltrate is a significant finding in patients with chronic hepatitis C. 335
Clinical course and management of acute and chronic viral hepatitis during pregnancy. 335
HCV genotypes in Sicily: is there any evidence of a shift? 331
Reactive hyperemia index (RHI) and cognitive performance indexes are associated with histologic markers of liver disease in subjects with non-alcoholic fatty liver disease (NAFLD): a case control study. 324
The presence of white matter lesions is associated with the fibrosis severity of nonalcoholic fatty liver disease 316
Association Between PNPLA3 rs738409 C>G Variant and Liver-Related Outcomes in Patients with Non-alcoholic Fatty Liver Disease 316
Effects of Eradicating Hepatitis C Virus Infection in Patients With Cirrhosis Differ With Stage of Portal Hypertension 313
Hepatic steatosis and insulin resistance are associated with severe fibrosis in patients with chronic hepatitis caused by HBV or HCV infection. 310
Clinical course and genetic susceptibility of primary biliary cirrhosis: Analysis of a prospective cohort 310
L’insulino-resistenza è il principale fattore indipendente correlato con l’aumentato rischio metabolico nelle donne affette da PCOS 308
Lean NAFLD: A Distinct Entity Shaped by Differential Metabolic Adaptation 307
HVR-1 quasispecies modifications occur early and are correlated to initial but not sustained response in HCV-infected patients treated with pegylated- or standard-interferon and ribavirin 306
Expansion of intestinal CD4+CD25(high) Treg cells in patients with ankylosing spondylitis: a putative role for interleukin-10 in preventing intestinal Th17 response 303
Characteristics of liver cirrhosis in Italy: results from a multicenter national study 301
Association of vitamin D serum levels and its common genetic determinants, with severity of liver fibrosis in genotype 1 chronic hepatitis C patients 293
Survival of Patients with Hepatocellular Carcinoma (HCC) Treated by Percutaneous Radio-Frequency Ablation (RFA) Is Affected by Complete Radiological Response 290
Clinical implications of the hyperdynamic syndrome in cirrhosis. 289
Clinical course and outcomes of drug-induced liver injury: Nimesulide as the first implicated medication. 288
Assessment of hepatitis C virus-RNA clearance under combination therapy for hepatitis C virus genotype 1: performance of transcription-mediated amplification assay 284
Obstructive Sleep Apnea Is Associated with Liver Damage and Atherosclerosis in Patients with Non-Alcoholic Fatty Liver Disease 282
Quantification of fibrosis by collagen proportionate area predicts hepatic decompensation in hepatitis C cirrhosis 281
Intrahepatic IgG/IgM plasma cells ratio helps in classifying autoimmune liver diseases. 279
The Hepatic Expression of Vitamin D Receptor is Inversely Associated with the Severity of Liver Damage in Genotype 1 Chronic Hepatitis C Patients. 279
751 RETINOL-BINDING PROTEIN 4 (RBP4): A NEW MARKER OF G1 HCV-INDUCED STEATOSIS 278
Steatosis affects the performance of liver stiffness measurement for fibrosis assessment in patients with genotype 1 chronic hepatitis C 277
A meta-analysis of single HCV-untreated arm of studies evaluating outcomes after curative treatments of HCV-related hepatocellular carcinoma 277
Clinical features and outcomes of patients with drug-induced autoimmune hepatitis: A retrospective cohort study. 271
Serum BLyS/BAFF predicts the outcome of acute hepatitis C virus infection 270
Insulin resistance and hyperandrogenism drive steatosis and fibrosis risk in young females with PCOS 270
Characteristics of HCV positive subjects referring to hospitals in Italy: a multicentre prevalence study on 6,999 cases 269
The impact of insulin resistance, serum adipocytokines and visceral obesity on steatosis and fibrosis in patients with chronic hepatitis C. 268
Expression of cytokeratin 7 and 20 in pathological conditions of the bile tract 268
PNPLA3 GG Genotype and Carotid Atherosclerosis in Patients with Non-Alcoholic Fatty Liver Disease 266
Role of IL-28B and inosine triphosphatase polymorphisms in efficacy and safety of Peg-Interferon and ribavirin in chronic hepatitis C compensated cirrhosis with and without oesophageal varices. 264
Adefovir for lamivudine resistant HBV: More than meets the eye. 263
Causal relationship of hepatic fat with liver damage and insulin resistance in nonalcoholic fatty liver 263
Overexpression of interleukin-23, but not interleukin-17, as an immunologic signature of subclinical intestinal inflammation in ankylosing spondylitis 262
Direct acting antivirals after successful treatment of early hepatocellular carcinoma improve survival in HCV-cirrhotic patients 262
Subclinical cardiovascular damage in patients with HCV cirrhosis before and after treatment with direct antiviral agents: a prospective study 262
Carotid atherosclerosis and chronic hepatitis C: A prospective study of risk associations. 260
MERTK rs4374383 polymorphism affects the severity of fibrosis in nonalcoholic fatty liver disease 260
Body Mass Index and Liver Stiffness Affect Accuracy of Ultrasonography in Detecting Steatosis in Patients With Chronic Hepatitis C Virus Genotype 1 Infection 260
High liver RBP4 protein content is associated with histological features in patients with genotype 1 chronic hepatitis C and with nonalcoholic steatohepatitis 258
The course of oesophagogastric varices in patients with cirrhosis after DAA-induced HCV clearance 258
Different doses of consensus interferon plus ribavirin in patients with hepatitis C virus genotype 1 relapsed after interferon monotherapy: a randomized controlled trial 257
Comparison of transient elastography and acoustic radiation force impulse for non-invasive staging of liver fibrosis in patients with chronic hepatitis C. 257
Retinol-binding protein 4 (RBP4) : a new marker of G1 HCV-induced steatosis 256
Acute hepatitis C: in search of the optimal approach to cure. 256
Clinical trial: High-dose furosemide plus small-volume hypertonic saline solutions vs. repeated paracentesis as treatment of refractory ascites. 256
An a priori prediction model of response to peginterferon plus ribavirin dual therapy in naïve patients with genotype 1 chronic hepatitis C 254
Anti-hepatitis A virus seroprevalence and seroconversion in a cohort of patients with chronic viral hepatitis 253
Seeding after radiofrequency ablation of hepatocellular carcinoma in patients with cirrhosis: a prospective study. 249
HBV-DNA suppression and disease course in HBV cirrhosis patients on long-term lamivudine therapy 247
Survival of patients with hepatocellular carcinoma in cirrhosis: a comparison of BCLC, CLIP and GRETCH staging systems 247
Predicting survival in patients with hepatocellular carcinoma treated by transarterial chemoembolisation 247
Hepatocellular carcinoma recurrence in patients with curative resection or ablation: impact of HCV eradication does not depend on the use of interferon 247
Cost-Effectiveness of Boceprevir or Telaprevir for Untreated Patients with Genotype 1 Chronic Hepatitis C 246
Coeliac disease: Oral ulcer prevalence, assessment of risk and association with gluten-free diet in children. 245
Industrial, not fruit fructose intake is associated with the severity of liver fibrosis in genotype 1 chronic hepatitis C patients 245
A Genetic and Metabolic Staging System for Predicting the Outcome of Nonalcoholic Fatty Liver Disease 245
LIPIDOMICS OF FATTY LIVER IN NAFLD AND HCV INFECTION: LIVER SPHYNGOLIPIDS AND FATTY ACIDS 243
Preoperative chemoradiotherapy for oesophageal cancer: a systematic review and meta-analysis 241
Phylogenetic Analysis of isolates from new cases of HBV infection in Southern Italy. 241
Association of vitamin D serum levels and its common genetic determinants with severity of liver fibrosis in genotype 1 chronic hepatitis C patients 241
A patient with acute hepatitis C and possible IFN toxicity [2] 241
Treatment of hepatocellular carcinoma in compensated cirrhosis with radio-frequency thermal ablation (RFTA): a prospective study 240
Hyperuricaemia: another metabolic feature affecting the severity of chronic hepatitis because of HCV infection. 240
Sarcopenia is associated with severe liver fibrosis in patients with non-alcoholic fatty liver disease 240
Add-on peginterferon alfa-2a to nucleos(t)ide analogue therapy for Caucasian patients with hepatitis B 'e' antigen-negative chronic hepatitis B genotype D. 239
Serology in adults with celiac disease: limited accuracy in patients with mild histological lesions. 238
Genetic predisposition to thrombophilia in inflammatory bowel disease 238
Cost-effectiveness of boceprevir or telaprevir for previously treated patients with genotype 1 chronic hepatitis C 238
Hepatitis B virus reactivation and alemtuzumab therapy 236
A Randomized, Placebo-Controlled Trial of Cenicriviroc for Treatment of Nonalcoholic Steatohepatitis with Fibrosis 236
ATTUALI ORIENTAMENTI NELLA DIAGNOSTICA DELLA MALATTIA DI HIRSCHSPRUNG 236
IL28B polymorphisms influence stage of fibrosis and spontaneous or interferon-induced viral clearance in thalassemia patients with hepatitis C virus infection. 235
Retinol-binding protein 4: a new marker of virus-induced steatosis in patients infected with hepatitis C virus genotype 1. 234
High sCD36 plasma level is associated with steatosis and its severity in patients with genotype 1 chronic hepatitis C 234
Liver disease in chelated transfusion-dependent thalassemics: the role of iron overload and chronic hepatitis C. 233
Phylogenetic Reconstruction of HCV Genotype 1b Dissemination in a Small City Centre: The Camporeale Model 233
Liver disease in chelated transfusion-dependent thalassemics: the role of iron and chronic hepatitis C 232
Oral Mucosa of celiac disease patients produces anti-endomysial and anti-transglutaminase antibodes. Diagnostic usefulness of an in vitro culture system 230
The aetiology of chronic hepatitis in Italy: results from a multicentre national study 230
PEG IFN alfa-2a vs. alfa-2b: And the winner is ...? 229
STAGING OF FIBROSIS BY LIVER STIFFNESS MEASUREMENT IN THALASSEMICS WITH IRON OVERLOAD 229
A woman with a long history of abdominal pain 229
TM6SF2 rs58542926 is not associated with steatosis and fibrosis in largecohort of patients with genotype 1 chronic hepatitis C 228
Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study. 225
Totale 27.774
Salva come PNG Salva come JPEG
Categoria #
all - tutte 293.270
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 293.270
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20223.892 0 0 0 148 154 230 279 410 686 637 383 965
2022/20236.755 759 1.533 114 648 701 1.047 402 457 683 48 254 109
2023/20242.362 139 416 162 195 196 514 231 138 42 54 18 257
2024/20257.000 197 424 422 734 192 235 426 467 560 881 889 1.573
2025/202627.305 1.523 726 1.370 1.986 2.511 4.037 3.756 2.810 2.604 3.594 1.317 1.071
2026/20277.215 1.535 1.361 3.284 1.035 0 0 0 0 0 0 0 0
Totale 85.652